There has been probably misplaced criticism of NIH for not making its finding of transmission of a bacteria between patients public, as well as wonder at the high-tech tools that enabled NIH to track down this killer organism.
These articles all overlook the more basic underlying problems, which I am aware of because of my practice as an Infectious Disease physician.
These relatively new, highly resistant strains of bacteria—carbapenem resistant Gram negative bacteria as Klebsiella and Acinetobacter—are not just at NIH. This is a widespread problem throughout much of the country.
